NCT01677039View on ClinicalTrials.gov

Study to Determine the Effects of Co-Administration of Alcohol on the Absorption of Oxycodone From a Proprietary Controlled-Release Formulation

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Healthy
Interventions
DRUG

Test formulation administered with water

single dose of 20 mg of test formulation with 240 mL of water

DRUG

Test formulation administered with 20% ethanol

single dose of 20 mg of test formulation with 240 mL of 20% ethanol in water

DRUG

Test formulation administered with 40% ethanol

single dose of 20 mg of test formulation with 240 mL of 40% ethanol

Trial Locations (1)

06511

Pfizer Investigational Site, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01677039 - Study to Determine the Effects of Co-Administration of Alcohol on the Absorption of Oxycodone From a Proprietary Controlled-Release Formulation | Biotech Hunter | Biotech Hunter